Alx Oncology Holdings (ALXO) Net Cash Flow (2019 - 2026)
Alx Oncology Holdings (ALXO) posted Net Cash Flow of $15.9 million for Q1 2026, up 325.08% sequentially from -$7.1 million in Q4 2025, and up 422.19% YoY from $3.0 million in Q1 2025.
Alx Oncology Holdings (ALXO) Net Cash Flow (2019 - 2026) Analysis & Trends
Alx Oncology Holdings has reported Net Cash Flow for 8 years, with the latest figure at $15.9 million in Q1 2026.
- Quarterly Net Cash Flow rose 422.19% year-over-year to $15.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.7 million (up 77.54% YoY) and the FY2025 annual result came in at -$1.2 million, up 75.33% from the prior year.
- Net Cash Flow climbed to $15.9 million in Q1 2026 per ALXO's latest filing, from -$7.1 million in the prior quarter.
- Over five years, Net Cash Flow peaked at $15.9 million in Q1 2026 and troughed at -$204.5 million in Q1 2022.
- A 5-year average of -$19.5 million and a median of -$232000.0 in 2022 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2022 and 2023: Net Cash Flow sank 4586.41% in 2022, then jumped 1316.38% in 2023.
- Over 5 years, Net Cash Flow stood at -$232000.0 in 2022, then surged by 1316.38% to $2.8 million in 2023, then plunged by 48.09% to $1.5 million in 2024, then slumped by 582.53% to -$7.1 million in 2025, then jumped by 325.08% to $15.9 million in 2026.
- According to Business Quant data, Net Cash Flow over the past three periods registered $15.9 million, -$7.1 million, and $4.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 407.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 17.81 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -496,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Alx Oncology Holdings | 270.90 Mn | 270.90 Mn | - | -9.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.40 Mn |
| Jun 30, 2026 | -9.40 Mn |
| Mar 31, 2026 | 15.91 Mn |
| Mar 31, 2026 | 15.91 Mn |
| Dec 31, 2025 | -7.07 Mn |
| Dec 31, 2025 | -7.07 Mn |
| Sep 30, 2025 | 4.14 Mn |
| Sep 30, 2025 | 4.14 Mn |
| Jun 30, 2025 | -1.31 Mn |
| Jun 30, 2025 | -1.31 Mn |
| Mar 31, 2025 | 3.05 Mn |
| Mar 31, 2025 | 3.05 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Dec 31, 2024 | 1.47 Mn |
| Sep 30, 2024 | 568,000.00 |
| Sep 30, 2024 | 568,000.00 |
| Jun 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Mar 31, 2024 | -8.37 Mn |
| Mar 31, 2024 | -8.37 Mn |